Désensibilisation aux pollens : présaisonnier ou cosaisonnier ? Pollen immunotherapy: pre-seasonal or co-seasonal treatment?

Pollen immunotherapy can be delivered either by the traditional subcutaneous route (SIT) or by sublingual-swallow immunotherapy (SLIT). Whatever the route of administration, the treatment is administered before the pollen season (pre-seasonal treatment) and during the pollen season (co-seasonal treatment). SLIT is safer and easier to administer than SIT, and this may be of special relevance in children. SLIT tolerance during the maintenance phase is excellent, even during the pollen season. © 2005 Publie par Elsevier SAS. Mots cles : Desensibilisation ; Pollens ; Enfant ; Traitement cosaisonnier ; Traitement presaisonnier

[1]  P. Rufin.  Désensibilisation aux pollens : présaisonnier ou cosaisonnier ? , 2005 .

[2]  A. Narkus,et al.  Efficacy and safety of preseasonal‐specific immunotherapy with an aluminium‐adsorbed six‐grass pollen allergoid , 2005, Allergy.

[3]  G. Passalacqua,et al.  Post‐marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  P. Keith,et al.  Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  S. Burastero,et al.  Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. , 2004, The Journal of allergy and clinical immunology.

[6]  P. Norman.  Immunotherapy: 1999-2004. , 2004, The Journal of allergy and clinical immunology.

[7]  G. Liss,et al.  Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. , 2004, The Journal of allergy and clinical immunology.

[8]  T. Casale.  Status of immunotherapy: current and future. , 2004, The Journal of allergy and clinical immunology.

[9]  T. Gandhi,et al.  Incorrect allergy injections: allergists' experiences and recommendations for prevention. , 2004, The Journal of allergy and clinical immunology.

[10]  G. Canonica,et al.  Sublingual or injection immunotherapy: the final answer? , 2004, Allergy.

[11]  A. Frew.  25. Immunotherapy of allergic disease. , 2003, The Journal of allergy and clinical immunology.

[12]  P. Rufin,et al.  Safety of Various Dosage Regimens during Induction of Sublingual Immunotherapy , 2002, International Archives of Allergy and Immunology.

[13]  J. Bousquet,et al.  Executive Summary of the Workshop Report
7–10 December 1999, Geneva, Switzerland , 2002, Allergy.

[14]  P. Eng,et al.  Long‐term efficacy of preseasonal grass pollen immunotherapy in children , 2002, Allergy.

[15]  Erkka Valovirta,et al.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.

[16]  C. Caffarelli,et al.  Preseasonal local allergoid immunotherapy to grass pollen in children: a double‐blind, placebo‐controlled, randomized trial , 2000, Allergy.

[17]  C. André,et al.  Safety of Sublingual-Swallow Immunotherapy in Children and Adults , 2000, International Archives of Allergy and Immunology.

[18]  G. Canonica,et al.  Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. , 1999, The Journal of allergy and clinical immunology.

[19]  Jarman,et al.  Short‐term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T‐cell responses, in patients with allergic rhinitis , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  G. Canonica,et al.  Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. , 1999, The Journal of allergy and clinical immunology.

[21]  J. de Blic,et al.  Immunotherapy in young children. , 2004, Clinical allergy and immunology.

[22]  L. Bernstein,et al.  Allergen immunotherapy: a practice parameter , 2003 .

[23]  S. Voltolini,et al.  Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. , 2001, Allergologia et immunopathologia.